Linda Llewellyn, Chief Human Resources Officer at Health catalyst (NASDAQ:), recently sold shares of the company, according to a filing with the Securities and Exchange Commission. On January 15, Llewelyn sold 6,442 shares of common stock at an average price of $5.7976 per share, for a total of approximately $37,348. Following this transaction, Llewelyn retains ownership of 92,260 shares in the company. This sale was made pursuant to a prearranged trading plan in March 2024, pursuant to Rule 10b5-1. The sale comes as Health Catalyst is trading near its 52-week low of $5.35, with the stock down more than 20% in the past. week. according to InvestingPro Through analysis, the stock appears to be undervalued at current levels, with analysts anticipating profitability this year despite recent market pressures. InvestingPro Subscribers can access 8 additional key insights into Health Catalyst, including detailed financial health scores and comprehensive valuation metrics.
In other recent news, Health Catalyst has been the focus of several important developments. The company announced a definitive agreement to acquire Upfront Healthcare Services (NASDAQ:), a patient engagement platform provider, which is expected to close in the first quarter of 2025. This acquisition is intended to enhance Health Catalyst's existing patient engagement portfolio and simplify patient care.
Health Catalyst also revealed its positive financial results for the third quarter of 2024, with the revenue mix shifting back towards software. Analysts such as KeyBanc Capital Markets, Piper Sandler and Stephens showed optimism in the company's performance, upgrading the stock and raising their price targets. KeyBanc upgraded Health Catalyst from sector weight to overweight, while Piper Sandler and Stephens increased their price targets on the company's stock.
In terms of analyst ratings, RBC Capital lowered Health Catalyst's stock target to $7, while maintaining its sector perform rating. This decision reflects the company's cautious stance while monitoring Health Catalyst's ability to convert new customer bookings into sustainable revenue growth. However, the company expressed optimism about Health Catalyst's 2025 bookings outlook, anticipating about 40 new customers.
These are the latest developments that provide investors with insights into Health Catalyst's financial health and growth trajectory. The company's actions and financial results, along with the perspectives of various analysis firms, provide a snapshot of Health Catalyst's current business landscape.
This article was created with the power of artificial intelligence and reviewed by an editor. For more information, see our terms and conditions.
